Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BMAC vs HA in Infiltrative Therapy for Osteoarthritis of the Ankle: Randomized Controlled Clinical Trial

NCT04883892 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.

NCT NCT04883892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04883892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BMAC vs HA in Infiltrative Therapy for Osteoarthritis of the Ankle: Randomized Controlled Clinical Trial
Lead sponsor
Istituto Ortopedico Rizzoli
Phase
Not applicable
Overall status
Terminated
Start date
December 15, 2021
Completion date
August 11, 2025
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankle osteoarthritis